Analysts have clear opinions on EBS.

Based on 6 analysts offering 12 month price targets for Emergent Biosolutions in the last 3 months. The average price target is $69.60 with a high forecast of $75.00 and a low forecast of $63.00. The average price target represents a 29.80% increase from
Emergent BioSolutions Inc. (EBS) is followed by 6 analysts on the street. Their average price target to be reached in the next 12 months has a
Boris Peaker from Cowen & Co. rates it a Hold with a target of $67.00.

Similarly, 7 days ago Dana Flanders of Guggenheim Reiterated a Buy with a target of $63.00.

The consensus on the street is Strong Buy.

What does Emergent BioSolutions Inc.(EBS) do ?
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public he

Emergent BioSolutions Inc.(EBS) Insider Trades

Multiple company employees have indulged in significant insider trading. Emergent BioSolutions Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that:

Dir, Zoon Kathryn C : S – Sale(-$54,314) of EBS in the trading session of 2019-11-18.

Dir Zoon Kathryn C : S – Sale(-$166,884) of EBS in the trading session of 2019-11-08.

Dir Richard Ronald : S – Sale+OE(-$309,180) of Emergent BioSolutions Inc. in the trading session of 2019-11-07.

Looking for stocks just like EBS? [Info can be found here: ]

Based on analyst reserch, several stocks are similar to EBS
They are:
– PFE [Info can be found here: ]
– PFNX [Info can be found here: ]
– GSK [Info can be found here: ]